While most meta-analyses were unable to detect a significant association between the use of GLP-1 RAs and any thyroid malignancies, a recent meta-analysis revealed that treatment with GLP-1RAs might be associated with a moderate risk of thyroid cancer [28,58,59]. This evidence concerns the gene GCG and thyroid gland carcinoma.